Moneycontrol

Budget 2023Budget 2023

PARTNERS

  • Tata AIA Life Insurance
  • Hafele
  • Motilal Oswal
Live Now : Nifty Banker 3.0 | India's First Retail Index Traders Online Conference.
Budget 2023
Budget 2023
you are here: HomeNewsIndia

COVID-19 | AstraZeneca vaccines sent by US might come from troubled Baltimore plant

The vaccines that the US will share may come from the controversial Baltimore plant which came under FDA investigation for faulty manufacturing, but Canada, which imported 1.5 million doses from this facility, said the supplies met quality specifications, and Mexico also found them safe.

April 27, 2021 / 01:35 PM IST
A vial of the Oxford University-AstraZeneca COVID-19 vaccine, which is produced in India and marketed as Covishield (Image: Reuters/Gleb Garanich)

A vial of the Oxford University-AstraZeneca COVID-19 vaccine, which is produced in India and marketed as Covishield (Image: Reuters/Gleb Garanich)

The United States on April 26 said it will begin sharing its entire stock of 60 million doses of the AstraZeneca COVID-19 vaccines with other countries, including India, after it clears the safety check.

India urgently needs vaccines against COVID-19 because of the record rise in cases in the relentless second wave of the pandemic.

However, the Baltimore plant where the doses were manufactured, has come under regulatory scrutiny over botched manufacturing of Johnson & Johnson's (J&J) COVID-19 vaccine and fears of contamination.

The US Food and Drug Administration on April 19 halted production at the plant, owned by Emergent BioSolutions, after the J&J vaccine shots were ruined.